{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T05:41:16Z","timestamp":1771306876625,"version":"3.50.1"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Hepatorenal syndrome (HRS) is encountered frequently in patients with end-stage liver disease and remains an important cause of morbidity and mortality in this patient population. This review will focus and provide updates on pathophysiology, assessment of kidney function, new definitions, and treatment and prevention of HRS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Pathophysiology of HRS has been elucidated more recently and in addition to hemodynamic changes, the role of systemic inflammatory response contributes significantly to this process. Assessment of kidney function in patients with liver cirrhosis remains challenging. Novel glomerular filtration rate equations have been developed in patients with liver disease to better estimate kidney function and changes made in the definition of acute kidney injury (AKI), which are more aligned with KDIGO criteria for AKI. Vasoconstrictors, especially terlipressin, along with albumin remain the mainstay of pharmacological treatment of HRS-AKI. Biomarkers have been useful in differentiating ATN from HRS at an early stage.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>HRS remains a significant cause of morbidity and mortality for patients with end-stage liver disease. Newer understanding of mechanisms in development and pathophysiology of HRS have helped with elucidation of the disease process.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mnh.0000000000000730","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:01:24Z","timestamp":1626307284000},"page":"501-506","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Advances in management of hepatorenal syndrome"],"prefix":"10.1097","volume":"30","author":[{"given":"Saro","family":"Khemichian","sequence":"first","affiliation":[{"name":"Division of Gastroenterology\/Liver, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Francoz","sequence":"additional","affiliation":[{"name":"Hepatology and Liver Intensive Care, Hospital Beaujon, Clichy, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitra K.","family":"Nadim","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,7,9]]},"reference":[{"key":"R1-20250729","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jhep.2020.04.043","article-title":"Changing epidemiology and outcomes of acute kidney injury in hospitalized patients with cirrhosis - a US population-based study","volume":"73","author":"Desai","year":"2020","journal-title":"J Hepatol"},{"key":"R2-20250729","doi-asserted-by":"crossref","first-page":"e0160394","DOI":"10.1371\/journal.pone.0160394","article-title":"Relevance of new definitions to incidence and prognosis of acute kidney injury in hospitalized patients with cirrhosis: a retrospective population-based cohort study","volume":"11","author":"Tandon","year":"2016","journal-title":"PLoS One"},{"key":"R3-20250729","doi-asserted-by":"crossref","first-page":"774","DOI":"10.2215\/CJN.12451018","article-title":"Hepatorenal syndrome","volume":"14","author":"Francoz","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"R4-20250729","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jhep.2019.07.002","article-title":"News in pathophysiology, definition and classification of hepatorenal syndrome: a step beyond the International Club of Ascites (ICA) consensus document","volume":"71","author":"Angeli","year":"2019","journal-title":"J Hepatol"},{"key":"R5-20250729","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fimmu.2019.00476","article-title":"Addressing profiles of systemic inflammation across the different clinical phenotypes of acutely decompensated cirrhosis","volume":"10","author":"Trebicka","year":"2019","journal-title":"Front Immunol"},{"key":"R6-20250729","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jhep.2009.11.025","article-title":"The evaluation of renal function and disease in patients with cirrhosis","volume":"52","author":"Francoz","year":"2010","journal-title":"J Hepatol"},{"key":"R7-20250729","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/hep.26704","article-title":"Glomerular filtration rate equations for liver-kidney transplantation in patients with cirrhosis: validation of current recommendations","volume":"59","author":"Francoz","year":"2014","journal-title":"Hepatology"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1097\/TP.0000000000003031","article-title":"Center-related bias in MELD scores within a liver transplant UNOS region: a call for standardization","volume":"104","author":"Verna","year":"2020","journal-title":"Transplantation"},{"key":"R9-20250729","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/hep.26886","article-title":"Creatinine- versus cystatine C-based equations in assessing the renal function of candidates for liver transplantation with cirrhosis","volume":"59","author":"De Souza","year":"2014","journal-title":"Hepatology"},{"key":"R10-20250729","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/hep.26556","article-title":"Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis","volume":"59","author":"Mindikoglu","year":"2014","journal-title":"Hepatology"},{"key":"R11-20250729","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/hep.30932","article-title":"MELD-GRAIL-Na: glomerular filtration rate and mortality on liver-transplant waiting list","volume":"71","author":"Asrani","year":"2020","journal-title":"Hepatology"},{"key":"R12-20250729","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/hep.30321","article-title":"A model for Glomerular Filtration Rate Assessment in Liver Disease (GRAIL) in the presence of renal dysfunction","volume":"69","author":"Asrani","year":"2019","journal-title":"Hepatology"},{"key":"R13-20250729","article-title":"Race adjustment in eGFR equations does not improve estimation of acute kidney injury events in patients with cirrhosis","author":"Mahmud","year":"2021","journal-title":"Dig Dis Sci"},{"key":"R14-20250729","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1186\/cc11188","article-title":"Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group","volume":"16","author":"Nadim","year":"2012","journal-title":"Crit Care"},{"key":"R15-20250729","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jhep.2014.12.029","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"62","author":"Angeli","year":"2015","journal-title":"J Hepatol"},{"key":"R16-20250729","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/hep.29303","article-title":"Significance of oliguria in critically ill patients with chronic liver disease","volume":"66","author":"Amathieu","year":"2017","journal-title":"Hepatology"},{"key":"R17-20250729","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jhep.2015.10.019","article-title":"Management of the critically ill patient with cirrhosis: Aa multidisciplinary perspective","volume":"64","author":"Nadim","year":"2016","journal-title":"J Hepatol"},{"key":"R18-20250729","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"R19-20250729","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jhep.2020.08.037","article-title":"Natural history of acute kidney disease in patients with cirrhosis","volume":"74","author":"Tonon","year":"2021","journal-title":"J Hepatol"},{"key":"R20-20250729","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/S0140-6736(18)30840-7","article-title":"Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial","volume":"391","author":"Caraceni","year":"2018","journal-title":"Lancet"},{"key":"R21-20250729","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa2022166","article-title":"A randomized trial of albumin infusions in hospitalized patients with cirrhosis","volume":"384","author":"China","year":"2021","journal-title":"N Engl J Med"},{"key":"R22-20250729","article-title":"Diagnosis, evaluation, and management of ascites and hepatorenal syndrome","author":"Biggins","year":"2021","journal-title":"Hepatology"},{"key":"R23-20250729","first-page":"CD011532","article-title":"Terlipressin versus other vasoactive drugs for hepatorenal syndrome","volume":"9","author":"Israelsen","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R24-20250729","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/apt.15836","article-title":"Real-world treatment patterns and outcomes using terlipressin in 203 patients with the hepatorenal syndrome","volume":"52","author":"Moore","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"R25-20250729","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa2008290","article-title":"Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome","volume":"384","author":"Wong","year":"2021","journal-title":"N Engl J Med"},{"key":"R26-20250729","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/ndt\/gfz048","article-title":"Reduction in acute kidney injury stage predicts survival in patients with type-1 hepatorenal syndrome","volume":"35","author":"Wong","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"R27-20250729","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1002\/hep.31529","article-title":"Response to terlipressin and albumin is associated with improved liver transplant outcomes in patients with hepatorenal syndrome","volume":"73","author":"Piano","year":"2020","journal-title":"Hepatology"},{"key":"R28-20250729","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/hep.30208","article-title":"Terlipressin is superior to noradrenaline in the management of acute kidney injury in acute on chronic liver failure","volume":"71","author":"Arora","year":"2020","journal-title":"Hepatology"},{"key":"R29-20250729","doi-asserted-by":"crossref","DOI":"10.1002\/lt.26065","article-title":"Feasibility and effectiveness of norepinephrine outside the intensive care setting for treatment of hepatorenal syndrome","author":"Kwong","year":"2021","journal-title":"Liver Transpl"},{"key":"R30-20250729","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.27709","article-title":"Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: a randomized trial","volume":"62","author":"Cavallin","year":"2015","journal-title":"Hepatology"},{"key":"R31-20250729","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1053\/j.ajkd.2016.02.041","article-title":"Changes in kidney function after transjugular intrahepatic portosystemic shunts versus large-volume paracentesis in cirrhosis: a matched cohort analysis","volume":"68","author":"Allegretti","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"R32-20250729","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1007\/s10620-020-06136-2","article-title":"Inpatient mortality benefit with transjugular intrahepatic portosystemic shunt for hospitalized hepatorenal syndrome patients","volume":"65","author":"Charilaou","year":"2020","journal-title":"Dig Dis Sci"},{"key":"R33-20250729","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2215\/CJN.03610417","article-title":"Prognosis of patients with cirrhosis and AKI who initiate RRT","volume":"13","author":"Allegretti","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"R34-20250729","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0140-6736(20)30531-6","article-title":"Delayed versus early initiation of renal replacement therapy for severe acute kidney injury: a systematic review and individual patient data meta-analysis of randomised clinical trials","volume":"395","author":"Gaudry","year":"2020","journal-title":"Lancet"},{"key":"R35-20250729","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1056\/NEJMoa2000741","article-title":"Timing of initiation of renal-replacement therapy in acute kidney injury","volume":"383","author":"Bagshaw","year":"2020","journal-title":"N Engl J Med"},{"key":"R36-20250729","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jhep.2017.04.022","article-title":"Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease","volume":"67","author":"Nadim","year":"2017","journal-title":"J Hepatol"},{"key":"R37-20250729","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1111\/j.1600-6143.2012.04176.x","article-title":"Simultaneous liver-kidney transplantation: a survey of US transplant centers","volume":"12","author":"Nadim","year":"2012","journal-title":"Am J Transplant"},{"key":"R38-20250729","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1111\/j.1600-6143.2012.04190.x","article-title":"Simultaneous liver-kidney transplantation summit: current state and future directions","volume":"12","author":"Nadim","year":"2012","journal-title":"Am J Transplant"},{"key":"R39-20250729","doi-asserted-by":"crossref","first-page":"848","DOI":"10.2215\/CJN.08480816","article-title":"New organ allocation system for combined liver-kidney transplants and the availability of kidneys for transplant to patients with stage 4-5 CKD","volume":"12","author":"Asch","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"R41-20250729","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/lt.23384","article-title":"Impact of the etiology of acute kidney injury on outcomes following liver transplantation: acute tubular necrosis versus hepatorenal syndrome","volume":"18","author":"Nadim","year":"2012","journal-title":"Liver Transpl"},{"key":"R42-20250729","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jhep.2016.05.025","article-title":"Kidney biomarkers in cirrhosis","volume":"65","author":"Francoz","year":"2016","journal-title":"J Hepatol"},{"key":"R43-20250729","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1053\/j.ajkd.2020.03.016","article-title":"Clinical application of kidney biomarkers in cirrhosis","volume":"76","author":"Allegretti","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"R44-20250729","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.2215\/CJN.09430913","article-title":"Urinary biomarkers and progression of AKI in patients with cirrhosis","volume":"9","author":"Belcher","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"R45-20250729","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/hep.30592","article-title":"Neutrophil gelatinase-associated lipocalin for assessment of acute kidney injury in cirrhosis: a prospective study","volume":"70","author":"Huelin","year":"2019","journal-title":"Hepatology"},{"key":"R46-20250729","doi-asserted-by":"crossref","first-page":"e00359","DOI":"10.14309\/ctg.0000000000000359","article-title":"Urinary NGAL as a diagnostic and prognostic marker for acute kidney injury in cirrhosis: a prospective study","volume":"12","author":"Allegretti","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"key":"R47-20250729","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/hep.30667","article-title":"External validation of a pretransplant biomarker model (REVERSE) predictive of renal recovery after liver transplantation","volume":"70","author":"Levitsky","year":"2019","journal-title":"Hepatology"}],"container-title":["Current Opinion in Nephrology &amp; Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MNH.0000000000000730","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T23:05:48Z","timestamp":1753830348000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MNH.0000000000000730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,9]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mnh.0000000000000730","relation":{},"ISSN":["1062-4821","1473-6543"],"issn-type":[{"value":"1062-4821","type":"print"},{"value":"1473-6543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,9]]}}}